Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review
http://www.companiesandmarkets.com/Summary-Company-Profile/medicis-pharmaceutical-corporation-financial-and-strategic-analysis-review-85271.asp
- Market - Healthcare and Medical
- Published Date - 13/06/2009
- Report Type - Company Profile
- Country - Global
- Number of Pages - 18
- Electronic - £73.00
- Site Licence - £146.00
- Corporate Licence - £218.00
Report Summary
Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review
Summary
Medicis Pharmaceutical Corporation (Medicis) is a pharmaceutical company engaged in providing products for the treatment of dermatological and podiatric conditions and aesthetics medicine. The company's branded products for various therapeutic categories include, Dynacin, Loprox, Plexion, Solodyn, Triaz, Vanos and Ziana, Ammonul, Buphenyl, Restylane, Perlane. The company has its operations spread across the US, Canada and Europe. The company is headquartered at Scottsdale, Arizona, United States
The Medicis Pharmaceutical Corporation - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Medicis Pharmaceutical Corporation. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Scope
- Provides key company information for business intelligence needs.
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial and strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitor's weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Table of Contents
Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 2
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
Overview 5
History 6
SWOT Analysis Overview 7
Overview 7
Medicis Pharmaceutical Corporation - Strengths 7
Strong financial performance 7
Broad Product Portfolio 7
Medicis Pharmaceutical Corporation - Weaknesses 7
Increasing Reliance on Primary products 7
Limited Customer Base 7
Legal Proceedings 7
Medicis Pharmaceutical Corporation - Opportunities 7
Strategic Collaborations and Acquisitions 7
Changing Demographics 8
Rising Healthcare Expenditure in the US 8
Medicis Pharmaceutical Corporation - Threats 8
Intense Competition 8
Tightening of FDA’s Regulatory Oversight 8
Impact of Financial Crisis 8
Key Competitors 9
Key Employees 9
Key Employee Biographies 10
Company Statement 11
Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Financial Ratios 13
Capital Market Ratios 13
Annual Ratios 13
Interim Ratios 14
Ratio Charts 15
Appendix 16
Methodology 16
Ratio Definitions 16
About Global Markets Direct 19
Contact Us 19
Disclaimer 19
List of Tables
Medicis Pharmaceutical Corporation, Key Facts 1
Medicis Pharmaceutical Corporation, Key Ratios 1
Medicis Pharmaceutical Corporation, Share Data 1
Medicis Pharmaceutical Corporation, Key Facts 4
Medicis Pharmaceutical Corporation, History 6
Medicis Pharmaceutical Corporation, Key Employees 9
Medicis Pharmaceutical Corporation, Key Employee Biographies 10
Medicis Pharmaceutical Corporation, Subsidiaries 12
Medicis Pharmaceutical Corporation, Ratios based on current share price 13
Medicis Pharmaceutical Corporation, Annual Ratios 13
Medicis Pharmaceutical Corporation, Interim Ratios 14
Currency Codes 16
Capital Market Ratios 16
Equity Ratios 17
Profitability Ratios 17
Cost Ratios 17
Liquidity Ratios 18
Leverage Ratios 18
Efficiency Ratios 18
List of Figures
Medicis Pharmaceutical Corporation, Performance Chart (2004 - 2008) 1
Medicis Pharmaceutical Corporation, Ratio Charts 15